AMC Sinks 9% as Cinema Stocks Sell Off Together; IMAX Drops 4%, Cinemark Slides 3%
Cinema stocks are tumbling together, and AMC is absorbing the steepest losses even after delivering a quarter that seemed to validate the entire recovery story. Something beyond earnings is driving this selloff across every theater name.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Movie theater stocks are selling off as a group, and shares of AMC Entertainment (NYSE:AMC) are absorbing the largest losses among the exhibitors. AMC stock is at $2.73, down 9% as the market session continues. The drop puts AMC stock at the front of a broad retreat across theatrical exhibition.
Meanwhile, IMAX (NYSE:IMAX) shares are at $52.61, down 4%, as the premium-screen supplier trades lower alongside the theater chains that operate its systems. Cinemark Holdings (NYSE:CNK) stock is at $36.28, down 3%, falling in step with the rest of the group. Together, AMC, IMAX and Cinemark share one film slate and one box-office calendar, so a turn in sentiment toward theatrical exhibition tends to reach all three at once.
Checking in on the equities market overall, the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is practically unchanged at $762.34. With the broad market holding steady, the pressure sits directly inside the cinema exhibitors, which marks the decline as a selloff specific to AMC, IMAX and Cinemark stocks. That split matters for AMC shareholders, because the selling traces to how the market views movie theaters as a group.
Cinema Trade Unwinds as a Group
Every listed theater name is lower, with AMC, IMAX and Cinemark shares falling together, and that shared direction points at the cinema trade being reversed as a whole. Without a verified company announcement from AMC, sector positioning stands out as the clearest driver of the move. Shares of AMC, IMAX and Cinemark rallied on one recovery story built around a stronger box office, and that same narrative is now working in reverse across all three.
Looking at the financial side of the equation, AMC’s Q2 2026 report delivered the operating leverage the recovery case rests on. AMC Entertainment reported that attendance rose 13.5% from a year earlier and adjusted EBITDA increased 69.6%, with total operating costs climbing far more slowly than revenues. Those figures came out well before the current selloff, so AMC’s quarter itself sits apart from the move.
The tension for AMC shareholders is that the company’s latest quarter delivered what the bull case required, and the stock is lower anyway, though what separates AMC stock from Cinemark and IMAX shares is the magnitude of the decline since all three are falling together. Among the three, the 9% slide in AMC stock is the largest, with shares of IMAX and Cinemark down 4% and 3%, respectively, at the softer end.
IMAX occupies a different seat in the same industry, supplying premium-screen technology to exhibitors, AMC among them, and because IMAX depends on theater attendance, a decline in sentiment toward the chains tends to spill over onto IMAX stock. An upcoming release slate that includes Dune: Part Three and Avengers: Doomsday remains the shared fundamental story behind IMAX, AMC and Cinemark alike.
What to Watch Next
Seasonality in AMC Entertainment’s cash generation adds a reason for caution on the recovery story. The company has stated that working capital generally contributes cash in the second and fourth quarters. It draws on it in the first and third, so one strong period falls short of establishing a full-year trend for AMC on its own. Market watchers may want to check for AMC’s next quarterly update to see whether that pattern holds.
AMC Entertainment’s latest quarter supports the operating story, yet the sharp swings in AMC stock argue for restraint. Investors weighing their exposure should adjust their holdings carefully given AMC’s standing as the hardest-hit name in a selloff that’s reaching every cinema stock.
Contact [email protected] for any questions or corrections.






